Dr. Stacy Remiszewski, former Director of Chemistry, Section Head for Oncology Chemistry at Hoffmann-La Roche, joins FORGE Life Science as Head Of Chemistry.
FORGE Life Science LLC is awarded a second grant from the NIH National Institute for Allergy and Infectious Disease titled, “A Single Antiviral to Treat Multiple Opportunistic Infections” (1R43AI114079-01). Read more
FORGE Life Science LLC grant titled, “Host-Targeted Mechanism of Action for Treatment of Seasonal and Pandemic Influenza”, is awarded by the NIH National Institute for Allergy and Infectious Diseases (1R43AI110048-01). Read more
FORGE Life Science LLC exclusively licenses Sirtuin-Antiviral Technology from Princeton University.
FORGE Life Science LLC leases BSL2+ facilities from the Pennsylvania Biotechnology Center.
